๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular analysis of PTEN and MXI1 in primary bladder carcinoma

โœ Scribed by David S. Wang; Kimberly Rieger-Christ; Jerilyn M. Latini; Ali Moinzadeh; John Stoffel; John A. Pezza; Kulvinder Saini; John A. Libertino; Ian C. Summerhayes


Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
139 KB
Volume
88
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Biallelic inactivating mutations and an
โœ Keisuke Kurose; Xiao-Ping Zhou; Tsutomu Araki; Charis Eng ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 135 KB

A tumor suppressor gene on chromosome sub-band 10q23.3, PTEN, is frequently mutated or deleted in a variety of human cancers. Germline mutations in PTEN, that encodes a dual-specificity phosphatase, have been implicated in two hamartomatumor syndromes that exhibit some clinical overlap, Cowden syndr

Mutational analysis of the PTEN gene in
โœ Xiao-Ping Zhou; You-Jun Li; Khรช Hoang-Xuan; Pierre Laurent-Puig; Karima Mokhtari ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 97 KB ๐Ÿ‘ 2 views

The PTEN gene, recently identified on chromosome 10q23, has been proposed to be a candidate tumor suppressor gene inactivated in multiple cancers including glial tumors. We investigated 47 glioblastomas (GBM), 14 anaplastic astrocytomas (AA), 6 non-pilocytic low-grade astrocytomas (LGA), 21 low-grad

Mutational analysis of the PTEN gene in
โœ Xiyun Shao; Raj Tandon; Ghassan Samara; Hiroaki Kanki; Hiroko Yano; Lanny G. Clo ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 121 KB ๐Ÿ‘ 2 views

## Loss of heterozygosity (LOH ) at chromosome band 10q23 occurs frequently in a wide variety of human tumors. A recently identified candidate tumor suppressor gene, PTEN located on 10q23, is mutated in multiple advanced cancers. To explore whether PTEN is associated with human squamous cell carci

Evaluation of urine CYFRA 21-1 for the d
โœ Benjamin Nisman; Vivian Barak; Amos Shapiro; Dragan Golijanin; Tamar Peretz; Dov ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 104 KB

## Abstract ## BACKGROUND The urinary concentration of soluble cytokeratin 19 fragments, measured by the CYFRA 21โ€1 assay, may be used for the noninvasive, early detection of bladder carcinoma. ## METHODS This prospective study examined urine samples from 325 patients. The authors included 152 p